Techniques: Fruit flies as models for neuropharmacological research

Trends in Pharmacological Sciences

Volumn 24, Issue 1, 2003, Pages 41-43

  Manev, Hari ^a   Dimitrijevic, Nikola ^a   Dzitoyeva, Svetlana ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSOCIATIVE MEMORY; BEHAVIOR; BRAIN DISEASE; DROSOPHILA MELANOGASTER; FOOD; GENE MUTATION; GENE SILENCING; GENETIC DISORDER; NERVE DEGENERATION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TECHNIQUE;

EID: 0037215655     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)00004-4     Document Type: Review

References (20)

1. Rein K., et al. The Drosophila standard brain. Curr. Biol. 12:2002;227-231.
2. Baier A., et al. Drosophila as a new model organism for the neurobiology of aggression? J. Exp. Biol. 205:2002;1233-1240.
3. Heberlein U. Genetics of alcohol-induced behaviors in Drosophila. Alcohol Res. Health. 24:2000;185-188.
4. Parr J., et al. The inebri-actometer: a device for measuring the locomotor activity of Drosophila exposed to ethanol vapor. J. Neurosci. Methods. 107:2001;93-99.
5. Li H., et al. Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster. Curr. Biol. 10:2000;211-214.
6. Leal S.M., Neckameyer W.S. Pharmacological evidence for GABAergic regulation of specific behaviors in Drosophila melanogaster. J. Neurobiol. 50:2002;245-261.
7. Kang H.-L., et al. Life extension in Drosophila by feeding a drug. Proc. Natl Acad. Sci. USA. 99:2002;838-843.
8. Andretic R., Hirsh J. Circadian modulation of dopamine receptor responsiveness in Drosophila melanogaster. Proc. Natl Acad. Sci. USA. 97:2000;1873-1878.
9. Carthew R.W. Gene silencing by double-stranded RNA. Curr. Opin. Cell Biol. 13:2001;244-248.
10. Dzitoyeva S., et al. Intra-abdominal injection of double-stranded RNA into anesthetized adult Drosophila triggers RNA interference in the central nervous system. Mol. Psychiatry. 6:2001;665-670.
11. Lindpainter K. The impact of pharmacogenetics and pharmacogenomics on drug discovery. Nat. Rev. Drug Discov. 1:2002;463-469.
12. Drier E.A., et al. Memory enhancement and formation by atypical PKM activity in Drosophila melanogaster. Nat. Neurosci. 5:2002;316-324.
13. Piccin A., et al. Efficient and heritable functional knock-out of an adult phenotype in Drosophila using a GAL4-driven hairpin RNA incorporating a heterologous spacer. Nucleic Acids Res. 29:2001;e55.
14. Giordano E., et al. RNAi triggered by symmetrically transcribed transgenes in Drosophila melanogaster. Genetics. 160:2002;637-648.
15. Uz T., et al. Circadian differences in behavioral sensitization to cocaine: putative role of arylalkylamine N-acetyltransferase. Life Sci. 70:2002;3069-3075.
16. Muqit M.M.K., Feany M.B. Modelling neurodegenerative diseases in Drosophila: a fruitful approach? Nat. Rev. Neurosci. 3:2002;237-243.
17. Steffan J.S., et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 413:2001;739-743.
18. Min K.T., Benzer S. Preventing neurodegeneration in the Drosophila mutant bubblegum. Science. 284:1999;1985-1988.
19. Costa E., et al. The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr. Opin. Pharmacol. 2:2002;56-62.
20. Sokolowski M.D. Drosophila: genetics meets behaviour. Nat. Rev. Genet. 2:2001;879-890.